Cancer
Cancer Ongoing 2021 North Shore NSW

Checkmate-078

A Study of Chemo Only Versus Chemo Plus Nivo With or Without BMS-986205, Followed by Post- Surgery Therapy With Nivo or Nivo and BMS-986205 in Patients With MIBC.

Trial overview

Disease
Genitourinary cancer
Topic
Checkmate-078
Description
A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapy plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post-Surgery Therapy with Nivolumab or Nivolumab and BMS-986205 in Participants with Muscle-Invasive Bladder Cancer.
Eligibility criteria
  • Muscle invasive bladder cancer
  • Planned for curative surgery 
Study details

The treatment involves pre-surgery chemotherapy with or without Nivolumab and BMS-98620. Curative surgery, followed by further treatment with Nivolumab and BMS-986205While on treatment there will be regular blood tests, urine tests, cystoscopies, and scans to monitor progress. At completion of treatment the study will continue to follow your progress.

Further information

For more information regarding this clinical trial click here.

Location

North Shore NSW